| Title: | Challenges posed by novel vaccines in a hyperlinked society both to doctors and the health of their patients |
|---|
| Authors: | ID Ihan, Alojz (Author) ID Univerza v Mariboru (Copyright holder) |
| Files: | Medicine,_law_&_society_2018_Ihan_Challenges_posed_by_novel_vaccines_in_a_hyperlinked_society_both_to_doctors_and_the_health_of_their_pa.pdf (444,21 KB) MD5: 2A301712827C0C551AC588BBF2B1A54F PID: 20.500.12556/dkum/a1216252-def3-492f-aeda-8814bc93cab2
http://journals.um.si/index.php/medicine/article/view/96
|
|---|
| Language: | English |
|---|
| Work type: | Scientific work |
|---|
| Typology: | 1.02 - Review Article |
|---|
| Organization: | PF - Faculty of Law
|
|---|
| Abstract: | Medicine in the developed world is becoming progressively more commercialized since patients (or, more accurately, medical consumers) are increasingly becoming the driving force of what we call medical progress. The doctors are primarily obliged to treat and help patients, but will always have also (commercial) temptation before him: to facilitate the consumer's desires and, with a warm heart, shoot to the far borders of medical knowledge and technology. A good example illustrating dilemma of beneficial vs commercial medicine are ethical challenges of some new vaccines developed recently. Since their earliest introduction in the late 18th century, vaccines have undoubtedly saved the lives of millions, while also fundamentally changing the way modern medicine is practiced. Many diseases that were once widespread are now eradicated, yet vaccine development faces ongoing challenges, including some important ethical considerations. Today there are over 300 vaccines in development and included in clinical trials. Among them, anti-addiction vaccines (Cocaine, Nicotine, Fentanyl, Heroin, Oxycodone) received a burst of media attention, because these vaccines could help people in recovery from addiction; however, many ethical and legal questions may arise before clinical use. |
|---|
| Keywords: | conflicts of interest, physicians, commercialization, public health |
|---|
| Publication status: | Published |
|---|
| Publication version: | Version of Record |
|---|
| Year of publishing: | 2018 |
|---|
| Number of pages: | str. 1-12 |
|---|
| Numbering: | Letn. 11, št. 1 |
|---|
| PID: | 20.500.12556/DKUM-72585  |
|---|
| ISSN: | 2463-7955 |
|---|
| UDC: | 614.2 |
|---|
| ISSN on article: | 2463-7955 |
|---|
| COBISS.SI-ID: | 33781209  |
|---|
| NUK URN: | URN:SI:UM:DK:OCCEWHGM |
|---|
| Copyright: | Univerza v Mariboru |
|---|
| Publication date in DKUM: | 09.10.2018 |
|---|
| Views: | 1817 |
|---|
| Downloads: | 194 |
|---|
| Metadata: |  |
|---|
| Categories: | Misc.
|
|---|
|
:
|
Copy citation |
|---|
| | | | Average score: | (0 votes) |
|---|
| Your score: | Voting is allowed only for logged in users. |
|---|
| Share: |  |
|---|
Hover the mouse pointer over a document title to show the abstract or click
on the title to get all document metadata. |